secwatch / observer
8-K/A filed April 6, 2026, 7:59 PM ET ticker AIRS CIK 0001870940
earnings confidence high sentiment negative materiality 0.65

AirSculpt posts Q4 rev $33.4M (-14.6% YoY); corrects adj EBITDA overstatement of $2.6M

Airsculpt Technologies, Inc.

2026-Q1 EPS reported -$0.03 revenue$39,389,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Airsculpt Technologies, Inc. reported fourth quarter and twelve months ended December 31, 2025 results: revenue $33.4 million, net income $1.3 million. Guidance reaffirmed.

Period
fourth quarter and twelve months ended December 31, 2025
Revenue
$33.4 million
Net income
$1.3 million
Guidance
reaffirmed
Result
reported results
Exact text from the filing
• Case volume was 2,604 for the fourth quarter of 2025, representing a 15.0% decline from the fiscal year 2024 fourth quarter case volume of 3,064; • Revenue declined 14.6% to $33.4 million from $39.2 million in the fiscal year 2024 fourth quarter; • Net loss for the quarter was $1.3 million compared to net loss of $5.0 million in the fiscal year 2024 fourth
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Airsculpt Technologies, Inc. reported full year 2026 results: revenue $151 to $157 million. Guidance initiated.

Period
full year 2026
Revenue
$151 to $157 million
Guidance
initiated
Result
guidance update
Exact text from the filing
The Company projects full year 2026 revenue and adjusted EBITDA guidance as follows: • Revenue of approximately $151 to $157 million • Adjusted EBITDA of approximately $15 to $17 million
View on SEC.gov

1349 earnings releases filed in the last 30 days. Browse all earnings releases →

Airsculpt Technologies, Inc. filing history →

Source: SEC EDGAR
accession 0001870940-26-000022
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.